TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers
Go back to TuHURA Biosciences Files Investigational New Drug Application for Evaluation of the TBS-2025 VISTA Inhibiting Antibody in Molecularly Defined Subsets of AML and Other Blood Related Cancers| (NASDAQ: HURA) | Delayed: 2.60 +0.03 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.57 | 52 Week High | $ | |||
| Open | $2.58 | 52 Week Low | $ | |||
| Day High | $2.67 | P/E | N/A | |||
| Day Low | $2.52 | EPS | $ | |||
| Volume | 478,194 | |||||
